Gao et al.
2024
Targeted mRNA nanoparticles ameliorate blood–brain barrier disruption postischemic stroke by modulating microglia polarization
Li et al.
2024
Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape
Huang et al.
2024
Unlocking the therapeutic applicability of LNP-mRNA: chemistry, formulation, and clinical strategies
Havaei et al.
2021
Pseudomonas exotoxin-based immunotoxins: over three decades of efforts on targeting cancer cells with the toxin
US7354579B2
(en )
2008-04-08
Method of treating cancer with a VEGF antagonist and an anti-proliferative agent
Kafle et al.
2024
Development of thermally stable mRNA-LNP delivery systems: current progress and future prospects
JP2025066807A
(ja )
2025-04-23
生体直交型組成物
Zhu et al.
2013
Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles
Qian et al.
2018
Hyaluronan reduces cationic liposome-induced toxicity and enhances the antitumor effect of targeted gene delivery in mice
JP5704788B2
(ja )
2015-04-22
癌の治療および過剰増殖性疾患の治療のための、免疫遺伝子療法と化学療法の組み合わせ
Koga et al.
2015
Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts
Xu et al.
2021
Inhaled RNA therapeutics for obstructive airway diseases: recent advances and future prospects
JPH07316074A
(ja )
1995-12-05
腫瘍および炎症性疾患を選択的に治療するために用いられる、壊死を引き起こす物質と、壊死により活性化される物質との組み合わせ
McGonigle et al.
2019
Neuropilin-1 drives tumor-specific uptake of chlorotoxin
Zhang et al.
2024
Prevent and reverse metabolic dysfunction-associated steatohepatitis and hepatic fibrosis via mRNA-mediated liver-specific antibody therapy
US6660264B1
(en )
2003-12-09
Treatment of intracellular infection
Suzuki et al.
2023
Differences and similarities of the intravenously administered lipid nanoparticles in three clinical trials: potential linkage between lipid nanoparticles and extracellular vesicles
Liu et al.
2020
Environmentally self-adaptative nanocarriers suppress glioma proliferation and stemness via codelivery of shCD163 and doxorubicin
TW201705977A
(zh )
2017-02-16
作為治療疫苗之奈米顆粒
Han et al.
2024
Enhancing cardioprotection through neutrophil‐mediated delivery of 18β‐glycyrrhetinic acid in myocardial ischemia/reperfusion injury
Shetab Boushehri et al.
2019
Challenges of using lipopolysaccharides for cancer immunotherapy and potential delivery-based solutions thereto
Ning et al.
2023
Gene reprogramming armed macrophage membrane-camouflaged nanoplatform enhances bionic targeted drug delivery to solid tumor for synergistic therapy
Wei et al.
2023
Cell-and subcellular organelle-targeting nanoparticle-mediated breast cancer therapy
Song et al.
2025
Microenvironments‐targeted nanomaterials for atherosclerosis therapy
Zhou et al.
2025
Self-assembled glycopeptide as a biocompatible mRNA vaccine platform elicits robust antitumor immunity